The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

Diagnostic Cytopathology

Volumn 38, Issue 12, 2010, Pages 874-879

  Rakha, E A ^a   Patil, S ^a   Abdulla, K ^a   Abdulkader, M ^a   Chaudry, Z ^a   Soomro, I N ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

mesothelioma; pleural fluid cytology; sensitivity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PLEURA EFFUSION; PLEURA FLUID; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 78649669043     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21303     Document Type: Article

References (44)

1. Sridhar KS, Doria R, Raub WA, Jr, Thurer RJ, Saldana M,. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992; 70: 2969-2979.
2. Legha SS, Muggia FM,. Pleural mesothelioma: Clinical features and therapeutic implications. Ann Intern Med 1977; 87: 613-621.
3. Pisani RJ, Colby TV, Williams DE,. Malignant mesothelioma of the pleura. Mayo Clin Proc 1988; 63: 1234-1244.
4. Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP,. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980; 68: 356-362.
5. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007; 62 (Suppl 2): ii1-ii19.
6. Department of Health. Mesothelioma framework: Advice for the NHS on how to organise services for Malignant Pleural Mesothelioma (MPM) patients to improve quality of care across the country. Department of Health, London, UK; 2007.
7. Ismail-Khan R, Robinson LA, Williams CC, Jr, Garrett CR, Bepler G, Simon GR,. Malignant pleural mesothelioma: A comprehensive review. Cancer Control 2006; 13: 255-263.
8. Boutin C, Schlesser M, Frenay C, Astoul P,. Malignant pleural mesothelioma. Eur Respir J 1998; 12: 972-981.
9. Elmes PC, Simpson JC,. The clinical aspects of mesothelioma. Q J Med 1976; 45: 427-449.
10. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ,. Malignant mesothelioma in a cohort of asbestos insulation workers: Clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988; 45: 182-187.
11. Sherman ME, Mark EJ,. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990; 114: 845-851.
12. Brenner J, Sordillo PP, Magill GB, Golbey RB,. Malignant mesothelioma of the pleura: Review of 123 patients. Cancer 1982; 49: 2431-2435.
13. Prakash UB, Reiman HM,. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: Analysis of 414 cases. Mayo Clin Proc 1985; 60: 158-164.
14. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES,. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111: 106-109.
15. Pedio G, Landolt-Weber U,. Cytologic presentation of malignant mesothelioma in pleural effusions. Exp Cell Biol 1988; 56: 211-216.
16. Whitaker D,. The cytology of malignant mesothelioma. Cytopathology 2000; 11: 139-151.
17. British Thoracic Society Standards of Care Committee. Statement on malignant mesothelioma in the United Kingdom. Thorax 2001; 56: 250-265.
18. Leong AS, Stevens MW, Mukherjee TM,. Malignant mesothelioma: Cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation. Semin Diagn Pathol 1992; 9: 141-150.
19. DiBonito L, Falconieri G, Colautti I, Bonifacio Gori D, Dudine S, Giarelli L,. Cytopathology of malignant mesothelioma: A study of its patterns and histological bases. Diagn Cytopathol 1993; 9: 25-31.
20. Peto J, Decarli A, La Vecchia C, Levi F, Negri E,. The European mesothelioma epidemic. Br J Cancer 1999; 79: 666-672.
21. Jones JS, Smith PG, Pooley FD, et al. The consequences of exposure to asbestos dust in a wartime gas-mask factory. IARC Sci Publ 1980; 30: 637-653.
22. McDonald JC, Harris JM, Berry G,. Sixty years on: The price of assembling military gas masks in 1940. Occup Environ Med 2006; 63: 852-855.
23. Peto J, Hodgson JT, Matthews FE, Jones JR,. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535-539.
24. Maskell NA, Gleeson FV, Davies RJ,. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: A randomised controlled trial. Lancet 2003; 361: 1326-1330.
25. Loddenkemper R, Boutin C,. Thoracoscopy: Present diagnostic and therapeutic indications. Eur Respir J 1993; 6: 1544-1555.
26. Naylor B,. The exfoliative cytology of diffuse malignant mesothelioma. J Pathol Bacteriol 1963; 86: 293-298.
27. Roberts GH, Campbell GM,. Exfoliative cytology of diffuse mesothelioma. J Clin Pathol 1972; 25: 577-582.
28. Triol JH, Conston AS, Chandler SV,. Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital. Acta Cytol 1984; 28: 37-45.
29. DiBonito L, Falconieri G, Colautti I, Bonifacio D, Dudine S,. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992; 36: 329-332.
30. Klempman S,. The exfoliative cytology of diffuse pleural mesothelioma. Cancer 1962; 15: 691-704.
31. Edge JR, Choudhury SL,. Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax 1978; 33: 26-30.
32. Jara F, Takita H, Rao UN,. Malignant mesothelioma of pleura: Clinicopathologic observation. N Y State J Med 1977; 77: 1885-1888.
33. Antman KH,. Current concepts: Malignant mesothelioma. N Engl J Med 1980; 303: 200-202.
34. Lewis RJ, Sisler GE, Mackenzie JW,. Diffuse, mixed malignant pleural mesothelioma. Ann Thorac Surg 1981; 31: 53-60.
35. Martensson G,. Diagnosing malignant pleural mesothelioma. Eur Respir J 1990; 3: 985-986.
36. Scamurra DO,. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1991; 115: 210.
37. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients. J Clin Oncol 1989; 7: 1157-1168.
38. Canto A, Blasco E, Casillas M, et al. Thoracoscopy in the diagnosis of pleural effusion. Thorax 1977; 32: 550-554.
39. Wilsher ML, Veale AG,. Medical thoracoscopy in the diagnosis of unexplained pleural effusion. Respirology 1998; 3: 77-80.
40. Wang Z, Tong ZH, Li HJ, et al. Semi-rigid thoracoscopy for undiagnosed exudative pleural effusions: A comparative study. Chin Med J (Engl) 2008; 121: 1384-1389.
41. Yamamoto T, Morohoshi T, Nagashima T,. [Clinical diagnosis of malignant pleural mesothelioma]. Kyobu Geka 2007; 60: 10-13.
42. Renshaw AA, Nappi D, Swanson S, Sugarbaker DJ,. Effusion cytology after extrapleural pneumonectomy for treatment of malignant mesothelioma. Am J Clin Pathol 1997; 107: 206-210.
43. Brock MV, Hooker CM, Yung R, et al. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 2005; 80: 1241-1247.
44. Davies HE, Sadler RS, Bielsa S, et al. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009; 180: 437-444.